Results 11 to 20 of about 577,222 (304)

BHFDSC/cvd-covid-tre-dashboard: BHF DSC CVD COVID TRE Dashboard Shiny App

, 2023
<p>This is a stable version of the BHF DSC CVD-COVID-UK/COVID-IMPACT Dataset Summary Dashboard.</p ...
Fionna Chalmers, LarsMurdock, anna-stevenson   +2 more
core   +2 more sources

Supplementary File for CVD risk

, 2023
CVD and ...
Qiang Liu (10863360)
core   +1 more source

Diagnostic in CVD processes by IR pyrometry [PDF]

, 2008
The control of CVD processes requires in situ analysis techniques and real time monitoring to identify the chemical species involved in the mechanism, to determine the growth kinetics and more generally to detect and analyze the dynamics of any event ...
Maury, Francis, Gasquères, Cyrille, Duminica, Florin-Daniel, Gasquères, Cyril   +3 more
core   +1 more source

Linear extended ArcJet-CVD - a new PECVD approach for continuous wide area coating under atmospheric pressure

, 2022
S.510-522A new type of DC-powered plasma source (LARGE) was developed and evaluated for continuous plasma-enhanced (PE) CVD under atmospheric pressure.
Mäder, G., Rohrer, C., Dzulko, M., Reichhold, C., Hopfe, V., Dani, I., Rogler, D., Theophile, E., Landes, K.   +8 more
core   +1 more source

Role of oxidative stress, gut microbiota and derived metabolites in the etiology and progression of nonalcoholic fatty liver disease

Redox Experimental Medicine, 2023
Nonalcoholic fatty liver disease or NAFLD is a complex and multifactorial liver disease that is affecting a majority of the world’s population now more than ever.
Ankita Das, Arka Jyoti De, Tanuja Mohanty, Palok Aich   +3 more
doaj   +1 more source

Nuts and CVD [PDF]

British Journal of Nutrition, 2015
Nuts are nutrient-dense foods with complex matrices rich in unsaturated fatty acids and other bioactive compounds, such asl-arginine, fibre, healthful minerals, vitamin E, phytosterols and polyphenols. By virtue of their unique composition, nuts are likely to beneficially affect cardiovascular health.
openaire   +2 more sources

Trimethylamine N-oxide: heart of the microbiota–CVD nexus? [PDF]

, 2020
We critically review potential involvement of trimethylamine-N-oxide (TMAO) as a link between diet, the gut microbiota and cardiovascular disease (CVD).
Du Toit, EF, Cox, AJ, Peart, JN, Headrick, JP, Naghipour, S   +4 more
core   +1 more source

Growth characteristics and texture of cubic boron nitride films produced by CVD

, 2022
S.262-265Thick cubic BN films have been grown by bias‐assisted DC jet plasma CVD (see Figure). The composition, morphology, and structure of the deposited films are studied.
Jiang, X., Helming, K., Zhang, W.J., Matsumoto, S.   +3 more
core   +1 more source

Assessing the Policy Landscape for Salt Reduction in South-East Asian and Latin American Countries – An Initiative Towards Developing an Easily Accessible, Integrated, Searchable Online Repository

Global Heart, 2021
Background: High dietary salt intake is an avoidable cause of hypertension and associated cardiovascular diseases (CVDs). Thus, salt reduction is recommended as one of the most cost-effective interventions for CVD prevention and for achieving the World ...
Aprajita Kaushik, Frank Peralta-Alvarez, Priti Gupta, Juan Carlos Bazo-Alvarez, Sandra Ofori, Kirsty Bobrow, Dan Monyeki, Renzo R. Guinto, Jill Baumgartner, Sailesh Mohan   +9 more
doaj   +1 more source

Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? [PDF]

, 2009
<p><b>Background:</b> Circulating inflammatory markers may more strongly relate to risk of fatal versus nonfatal cardiovascular disease (CVD) events, but robust prospective evidence is lacking.
Jukema, J.W., Westendorp, R.G.J., Lowe, G.D., Murray, H.M., Cobbe, S., de Craen, A.J.M., Blauw, G.J., Ford, I., Welsh, P.I., Murphy, M.B., Buckley, B.M., Macfarlane, P.W., Stott, D.J., Sattar, N.A., Shepherd, J., Gerard J Blauw, Chris J Packard, Ian Ford, Ford Ian, David J Stott, Sattar Naveed, Welsh Paul, Stuart Cobbe, Westendorp Rudi G. J., Lowe Gordon D., Heather M Murray, Paul Welsh, Murphy Michael B., Macfarlane Peter W., Peter W Macfarlane, James Shepherd, Buckley Brendan M., Stott David J., Cobbe Stuart, Jukema J. Wouter, J Wouter Jukema, Murray Heather M., Anton J M de Craen, de Craen Anton J. M., Packard Chris J., Naveed Sattar, Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Study Group, Blauw Gerard J., Brendan M Buckley, Michael B Murphy, Rudi G J Westendorp, Gordon D Lowe, Shepherd James, Packard, Chris J, Westendorp, Rudi G J, Blauw, Gerard J, de Craen, Anton J M, Welsh, Paul, Ford, Ian, Murray, Heather M, Stott, David J, Lowe, Gordon D, Jukema, J Wouter, Murphy, Michael B, Macfarlane, Peter W, Shepherd, James, Sattar, Naveed, Cobbe, Stuart, Buckley, Brendan M   +63 more
core   +3 more sources